September 2013 Oncology
Oral antineoplastics have advantages, but patient adherence is a concern.
Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.
Why are computerized drug-drug interaction alerts usually ignored?
Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.
The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis
Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Drug Approach Targets KRAS-Mutant Lung Cancer to Overcome Therapy Resistance
2
'Beyond Weight Loss': Emerging Studies Show How GLP-1 Receptor Agonists May Impact Addiction Behaviors
3
FDA Approves Denosumab Biosimilars Boncresa and Oziltus for Osteoporosis-, Cancer-Related Bone Loss
4
Ultra-Processed Food Consumption May Worsen Breast Cancer Outcomes Among Black Women
5